| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes ADVANCE Collaborative Group New England journal of medicine 358 (24), 2560-2572, 2008 | 9829 | 2008 |
| Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a … A Patel The Lancet 370 (9590), 829-840, 2007 | 3219 | 2007 |
| Severe hypoglycemia and risks of vascular events and death S Zoungas, A Patel, J Chalmers, BE De Galan, Q Li, L Billot, M Woodward, ... New England Journal of Medicine 363 (15), 1410-1418, 2010 | 1744 | 2010 |
| Intensive glucose control and macrovascular outcomes in type 2 diabetes FM Turnbull, C Abraira, RJ Anderson, RP Byington, JP Chalmers, ... Diabetologia 52, 2288-2298, 2009 | 1394 | 2009 |
| Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis M Jun, C Foote, J Lv, B Neal, A Patel, SJ Nicholls, DE Grobbee, A Cass, ... The Lancet 375 (9729), 1875-1884, 2010 | 1197 | 2010 |
| Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes T Ninomiya, V Perkovic, BE De Galan, S Zoungas, A Pillai, M Jardine, ... Journal of the American Society of Nephrology 20 (8), 1813-1821, 2009 | 1123 | 2009 |
| Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis CA Emdin, K Rahimi, B Neal, T Callender, V Perkovic, A Patel Jama 313 (6), 603-615, 2015 | 1044 | 2015 |
| World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions S Kaptoge, L Pennells, D De Bacquer, MT Cooney, M Kavousi, G Stevens, ... The Lancet global health 7 (10), e1332-e1345, 2019 | 819 | 2019 |
| Follow-up of blood-pressure lowering and glucose control in type 2 diabetes S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ... New England Journal of Medicine 371 (15), 1392-1406, 2014 | 815 | 2014 |
| Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data Blood Pressure Lowering Treatment Trialists' Collaboration The Lancet 384 (9943), 591-598, 2014 | 646 | 2014 |
| Cholesterol, coronary heart disease, and stroke in the Asia Pacific region Asia Pacific Cohort Studies Collaboration International journal of epidemiology 32 (4), 563-572, 2003 | 606 | 2003 |
| Task shifting for non-communicable disease management in low and middle income countries–a systematic review R Joshi, M Alim, AP Kengne, S Jan, PK Maulik, D Peiris, AA Patel PloS one 9 (8), e103754, 2014 | 542 | 2014 |
| Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes S Zoungas, M Woodward, Q Li, ME Cooper, P Hamet, S Harrap, S Heller, ... Diabetologia 57, 2465-2474, 2014 | 520 | 2014 |
| Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant … K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy, R Ramakrishnan, ... The Lancet 397 (10285), 1625-1636, 2021 | 508 | 2021 |
| Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region Asia Pacific Cohort Studies Collaboration Circulation 110 (17), 2678-2686, 2004 | 484 | 2004 |
| Risk prediction in patients with heart failure: a systematic review and analysis K Rahimi, D Bennett, N Conrad, TM Williams, J Basu, J Dwight, ... JACC: Heart Failure 2 (5), 440-446, 2014 | 479 | 2014 |
| Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial S Thom, N Poulter, J Field, A Patel, D Prabhakaran, A Stanton, ... Jama 310 (9), 918-929, 2013 | 479 | 2013 |
| Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds S Zoungas, J Chalmers, T Ninomiya, Q Li, ME Cooper, S Colagiuri, ... Diabetologia 55, 636-643, 2012 | 415 | 2012 |
| Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from … S Zoungas, BE De Galan, T Ninomiya, D Grobbee, P Hamet, S Heller, ... Diabetes care 32 (11), 2068-2074, 2009 | 384 | 2009 |
| Intensive glucose control improves kidney outcomes in patients with type 2 diabetes V Perkovic, HL Heerspink, J Chalmers, M Woodward, M Jun, Q Li, ... Kidney international 83 (3), 517-523, 2013 | 382 | 2013 |
Bruce NealUNSW Sydney, Imperial College London,The George Institute for Global Health,University of SydneyE-mail confirmado em georgeinstitute.org.au
